6-K 1 fresen_6k.txt FORM 6-K ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form 40-F [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [X] If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82 ================================================================================ This Report on Form 6-K shall be incorporated by reference in the Registration Statement on Form F-4 (Registration No. 333-128899) filed October 7, 2005 by Fresenius Medical Care AG (the "Company") as amended by Amendment No. 1 filed November 17, 2005, and shall be part thereof and the prospectus included therein from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished by the Company with the U.S. Securities and Exchange Commission. Attached hereto as Exhibit 99.1 is a press release issued on December 23, 2005 announcing an extension of Expiration Date for Tender Offer and Consent Solicitation for the 9% Senior Subordinated Notes of Renal Care Group, Inc. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: December 23, 2005 FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT By: /s/ BEN LIPPS ------------------------------------- Name: Dr. Ben Lipps Title: Chief Executive Officer and Chairman of the Management Board By: /s/ LAWRENCE A. ROSEN ------------------------------------- Name: Lawrence A. Rosen Title: Chief Financial Officer